Home » Topics » Regulatory » Patents

Patents
RSS

Recent patents describe new compounds for thrombotic disorders

Nov. 13, 2006

Novel cannabinoid CB1 receptor antagonists emerge from Pfizer R&D

Nov. 13, 2006

Recent patents describe novel antidiabetic agents

Nov. 13, 2006

Novel compounds with potential for treatment of gastrointestinal disorders reported

Nov. 10, 2006

Novel antiinfective agents disclosed in recent patent literature

Nov. 10, 2006

New anticancer agents patented

Nov. 10, 2006

Novel agents for cardiovascular disorders disclosed in recent patents

Nov. 9, 2006

Recent Tibotec and Trimeris patents report novel agents for HIV infection

Nov. 9, 2006

Recent Elan, Xenon and Gruenenthal patents disclose novel analgesic agents

Nov. 9, 2006

Recent patents cover new therapeutic agents for cancer

Nov. 8, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....